PT-141 (Bremelanotide)

Research peptide overview

Overview

PT-141, also known as Bremelanotide, is a synthetic peptide studied for its interaction with melanocortin receptors in the central nervous system. In research settings, it has been explored for its role in modulating behavioral and neuroendocrine pathways.

Research Applications

Preclinical and experimental research has explored PT-141 in the following areas:

• Melanocortin receptor signaling pathways
• Behavioral and neuroendocrine response models
• Central nervous system signaling research
• Hormonal pathway modulation

These are research areas, not approved therapeutic claims.

Research Overview

Published studies and experimental literature have discussed PT-141 in connection with:

• Activation of melanocortin receptors (MC receptors)
• Central nervous system signaling pathways
• Behavioral response modulation under controlled conditions
• Neuroendocrine system interactions

The evidence base includes preclinical and clinical research exploring its mechanisms of action in controlled environments.

Mechanism

In experimental settings, PT-141 acts as an agonist of melanocortin receptors, particularly MC3R and MC4R. This interaction is studied for its effects on central nervous system signaling and downstream neuroendocrine responses.

Research Contexts

PT-141 has been studied in experimental contexts such as:

• Neuroendocrine research models
• Behavioral response studies
• Central nervous system signaling investigations
• Hormonal pathway research

Product Reference

BioJak PT-141 (Bremelanotide)
Lyophilized peptide powder
Standard 6 mL vial format
Multiple concentration options available

Important Notice

This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.